Wednesday, April 15, 2015 from 1pm to 2pm EDT
Corticosteroids are the only treatment documented to improve strength and increase muscle mass in boys with Duchenne muscular dystrophy (Duchenne). Despite an American Academy of Neurology practice guideline and Cochrane report recommending their use, corticosteroid use is haphazard in timing, dosage schedule, and duration and in some countries not prescribed to most patients. The FOR-DMD study examines the three most commonly prescribed corticosteroid regimens. This webinar will include a presentation of the aims of the FOR-DMD study, along with discussion of why the study is particularly relevant in regard to current/future DMD clinical trials. A parent of one of the FOR-DMD study subjects will be available for participant questions, as well.
Questions can be submitted in advance to email@example.com (subject line: FOR-DMD Webinar).